Published: 22 July 2020
Author(s): Marco Centola, Alessandro Maloberti, Diego Castini, Simone Persampieri, Ludovico Sabatelli, Giulia Ferrante, Stefano Lucreziotti, Nuccia Morici, Alice Sacco, Fabrizio Oliva, Paola Rebora, Cristina Giannattasio, Antonio Mafrici, Stefano Carugo
Issue: January 2021
Section: Original article

High levels of serum uric acid (SUA) have been showed to increase the risk of cardiac adverse events, independently of traditional cardiovascular risk factors [1,2]. Hyperuricemia has been also associated with high mortality rates in patients with acute myocardial infarction (AMI) [3]. However, the relationship between SUA and cardiovascular diseases is not fully elucidated [4]. In particular the role and the prognostic relevance of increased SUA in patients with acute coronary syndrome (ACS) are still under debate [5–7].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.